A Study Called GUS to Understand How Much of the Contrast Agent Gadavist is Used and How Much is Wasted in Two Different Containers (Single-dose Vials and Imaging Bulk Packages ) in a Real-world Setting

CompletedOBSERVATIONAL

Enrollment

1,602

Participants

Timeline

Start Date

November 3, 2022

Primary Completion Date

March 28, 2023

Study Completion Date

April 27, 2023

Conditions

Contrast Enhancement in Magnetic Resonance Imaging

Interventions

DRUG

Gadobutrol (Gadavist/Gadovist, BAY86-4875)

At discretion of attending physician

Trial Locations (2)

Allegheny General Hospital, Pittsburgh

Western Pennsylvania Hospital, Pittsburgh